Search - tctmd.com

Displaying 761 - 780 of 1751

Sort: Relevancy | Date

News Daily News

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

July 08, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Industry News

CardioDx Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test

July 07, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Leah Lawrence

July 03, 2014

News Daily News

Un Estudio sobre el Manejo de Cuadros de STEMI en China Desvela Carencias Importantes en el Tratamiento

L.A. McKeown

June 27, 2014

News Daily News

Subestudio del STREAM: Los STEMI Abortados son Más Frecuentes con una Estrategia Precoz de Fibrinolisis

June 27, 2014

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

News Daily News

STREAM Substudy: Aborted STEMI More Common with Strategy of Early Fibrinolysis

June 27, 2014

News Daily News

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Yael L. Maxwell

June 27, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

Presentation

STEMI in China from 2001-2011 (The China PEACE-Retrospective Acute Myocardial Infarction Study)

Presenter: Lixin Jiang

June 24, 2014

News Daily News

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Yael L. Maxwell

June 24, 2014

News Daily News

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Yael L. Maxwell

June 24, 2014

News Industry News

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

June 19, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Caitlin E. Cox

June 13, 2014

News Industry News

First Patient Enrolled in PROSPECT II Clinical Trial

June 13, 2014

Advertisement

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

CardioDx Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Un Estudio sobre el Manejo de Cuadros de STEMI en China Desvela Carencias Importantes en el Tratamiento

Subestudio del STREAM: Los STEMI Abortados son Más Frecuentes con una Estrategia Precoz de Fibrinolisis

Study of STEMI Care in China Exposes Crucial Treatment Gaps

STREAM Substudy: Aborted STEMI More Common with Strategy of Early Fibrinolysis

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

STEMI in China from 2001-2011 (The China PEACE-Retrospective Acute Myocardial Infarction Study)

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

First Patient Enrolled in PROSPECT II Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content